Clinical Trial Update: REQUIP (Ropinirole Hydrochloride) IR Long-Term Phase 4 Study [Phase 4]

View source ↗

Summary

This document reports the completion and posting of results for a long-term Phase 4 trial of REQUIP (ropinirole hydrochloride IR) in Parkinson's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• REQUIP (ropinirole hydrochloride)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Parkinson Disease, Parkinson's Disease | Phase 4 | Status: COMPLETED | Results posted: 2010-12-15